HomeTagsSpanish Interministerial Commission

Spanish Interministerial Commission

Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy

Popular

Frequently Asked Questions About Elevidys Used for DMD

Can Ekinci - August 21, 2026

Must Read

GEN6050X Exon 50 Skipping Base Editing Drug: One-Year Results Show Encouraging Progress for Duchenne Muscular Dystrophy

Sarcomatrix Plans First Human Trial of S-969 for Duchenne Muscular Dystrophy in 2027

7 Breakthrough DMD Research Programs That Could Transform Duchenne Treatment in 2026

About us

Together, we will keep fighting for better treatments and access for everyone with Duchenne.

Powered by Hostinger

Latest Articles

Deramiocel Shows Positive 24-Month HOPE-3 Results in Duchenne

Press Releases October 5, 2026 0

Capricor Therapeutics has reported new results from the HOPE-3...

Ractigen Therapeutics Reports Positive First-in-Human Data for RAG-18 in Duchenne

Press Releases October 4, 2026 0

Ractigen Therapeutics has presented positive first-in-human data for RAG-18...

Entrada Therapeutics’ ENTR-601-44 Shows Dose-Dependent Exon 44 Skipping in Early PK/PD Data

Press Releases October 3, 2026 0

Entrada Therapeutics’ ENTR-601-44 is an investigational therapy designed for...

Most Popular

Frequently Asked Questions About Elevidys Used for DMD

Approved Therapies August 21, 2026 0

Duchenne muscular dystrophy (DMD) is a genetic condition that...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Editorials April 10, 2026 0

The landscape of potential new gene therapies for Duchenne...

The Brutal Truth: Why Duchenne Muscular Dystrophy Treatment Costs Are Out of Control

Editorials April 6, 2026 0

The duchenne muscular dystrophy treatment cost has become one...

© 2024 - 2026 DMD Warrior. All rights reserved.